menu
    • menu

    Company profile for BeOne Medicines

    Pfanstiehl, a global leader in the manufacture of cGMP high purity, low endotoxin, low metals (HPLE-LM)TM injectable grade excipients.

    Virtual Booth

    Contact Supplier

    Global Pharma Healthcare: Setting the global benchmark in quality, innovation, and care

    Virtual Booth

    Contact Supplier

    Transo-Pharm GmbH works globally to supply Active Pharmaceutical Ingredients adhering to the highest quality & GMP standards.

    Virtual Booth

    Contact Supplier

    Phyton is a World Leader in Plant Cell Fermentation Technology and Commercial Manufacturing.

    Virtual Booth

    Contact Supplier

    Farmak works in the development, production and marketing of APIs, Intermediates & Specialties// FDA inspected.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    BeOne Medicines, based in Switzerland, is a global oncology company dedicated to discovering and developing innovative, affordable cancer treatments. Its portfolio covers both hematology and solid tumors, and it advances its diverse pipeline through strong in-house expertise and strategic collaborations. With over 11,000 employees across six continents, BeOne is driven by a mission to significantly expand access to life-changi...
    BeOne Medicines, based in Switzerland, is a global oncology company dedicated to discovering and developing innovative, affordable cancer treatments. Its portfolio covers both hematology and solid tumors, and it advances its diverse pipeline through strong in-house expertise and strategic collaborations. With over 11,000 employees across six continents, BeOne is driven by a mission to significantly expand access to life-changing medicines for cancer patients worldwide.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    BeOne MedicinesUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    Cambridge, Massachusetts
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://beonemedicines.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/beonemedicines/
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/Beonemedicines

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Beone Medicines To Present At J.P. Morgan Healthcare Conference
    Beone Medicines To Present At J.P. Morgan Healthcare Conference

    23 Dec 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251223138985/en/BeOne-Medicines-to-Present-at-the-44th-Annual-J.P.-Morgan-Healthcare-Conference

    BUSINESSWIRE
    23 Dec 2025
    Share Share
    Beone Medicines Receives FDA Fast Track For BGB-B2033
    Beone Medicines Receives FDA Fast Track For BGB-B2033

    18 Dec 2025

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2025-12-18/beone-medicines-granted-us-fda-fast-track-designation-for-bgb-b2033-as-treatment-for-hepatocellula

    PHARMIWEB
    18 Dec 2025
    Share Share
    Senhwa & BeOne Medicines Ink Deal Targeting Cold Tumors
    Senhwa & BeOne Medicines Ink Deal Targeting Cold Tumors

    10 Dec 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/senhwa-biosciences-and-beone-medicines-announces-a-clinical-supply-agreement-to-address-the-challenge-of-cold-tumors-302638027.html

    PR NEWSWIRE
    10 Dec 2025
    Share Share
    BRUKINSA Achieves 74% 6-Year PFS In Treatment-Naïve Cll
    BRUKINSA Achieves 74% 6-Year PFS In Treatment-Naïve Cll

    08 Dec 2025

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2025-12-08/brukinsa-delivers-landmark-74-6-year-pfs-in-patients-with-treatment-naïve-chronic-lymphocytic-leuke

    PHARMIWEB
    08 Dec 2025
    Share Share
    Sonrotoclax Shows Promise in B-Cell Malignancies at ASH 2025
    Sonrotoclax Shows Promise in B-Cell Malignancies at ASH 2025

    07 Dec 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251207830814/en/Sonrotoclax-Data-at-ASH-2025-Confirm-Foundational-Potential-Across-B-cell-Malignancies

    BUSINESSWIRE
    07 Dec 2025
    Share Share
    FDA Grants Priority Review To Sonrotoclax
    FDA Grants Priority Review To Sonrotoclax

    26 Nov 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251126490630/en/U.S.-FDA-Grants-Priority-Review-to-Sonrotoclax-for-the-Treatment-of-Relapsed-or-Refractory-Mantle-Cell-Lymphoma

    BUSINESSWIRE
    26 Nov 2025
    Share Share

    FDA Orange Book

    read-more
    read-more

    South Africa

    read-more
    read-more

    01

    Brand Name : BRUKINSA

    U.S.A
    Biotech Showcase
    Not Confirmed
    arrow

    Brand Name : BRUKINSA

    U.S.A
    arrow
    Biotech Showcase
    Not Confirmed
    • fda
    • EDQM
    • WHO-GMP
    Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

    Regulatory Info : Originator

    Registration Country : South Africa

    ZANUBRUTINIB

    BeOne Medicines

    Dosage Form : CAP

    Dosage Strength : 80mg

    Packaging : 120X1mg

    Brand Name : BRUKINSA

    Approval Date :

    Application Number :

    Regulatory Info : Originator

    Registration Country : South Africa

    blank

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search